MedTrace Logo

Impact of the ProbeFix on the Workflow of Pharmacological Stress Echocardiography Examinations

NCT04016363 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-10-15

No results posted yet for this study

Summary

Pharmacological stress-echocardiography examinations are routinely performed in daily clinical practice. Usually, the echo probe is manually placed on the patient's thorax by the physician. The ProbeFix is a novel device, enabling the fixation of the ultrasound probe on the patient's thorax. Therefore, there is no need to manually hold the probe. This may improve the standardization of the examination and my reduce its duration. The present trial will investigate, whether the utilization of the ProbeFix reduces the duration of stress-echocardiography examinations and improves standardization of image acquisition.

Conditions

Interventions

OTHER

ProbeFix

ProbeFix vs. manual hold of the ultrasound probe during pharmacological stress-echocardiography examinations

OTHER

Manual hold

ProbeFix vs. manual hold of the ultrasound probe during pharmacological stress-echocardiography examinations

Sponsors & Collaborators

  • Amir Abbas Mahabadi

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-12-30
Completion
2020-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04016363 on ClinicalTrials.gov